All In MedTech

Device Trial Radar · NCT07649798

Initial Study of a MOTHER-DAUGHTER SIDE-BRANCH ACCESS™ DES System (FIH Feasibility Study)

Initial Study of a MOTHER-DAUGHTER SIDE-BRANCH ACCESS™ DES System for Bifurcation Lesions (First-in-Human, Feasibility Study)

Last checked: Nov 20, 2026Latest source record: Jun 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

13

Actual

Start

Sep 16, 2025

Primary completion

Nov 19, 2025

Study completion Nov 19, 2028

Sponsor

Lead sponsor
Advanced Bifurcation Systems Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jun 16, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Device feasibility
FDA-regulated device
Yes
Who can join
All sexes, from 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This first in human feasibility study is designed to evaluate the feasibility MD-SBA DES in subjects undergoing percutaneous coronary intervention (PCI) to treat bifurcation lesions.

Conditions

  • Coronary Angioplasty
  • Bifurcation Coronary Artery Disease
  • Ischemic Heart Disease (IHD)
  • Percutaneous Coronary Intervention (PCI)

Interventions

  • MD-SBA DES SystemDevice

    The MD-SBA DES System is a single use, minimally invasive combination product that consists of a cobalt chromium metal coronary stent, coated with sirolimus in a PEA/BHT matrix, on a rapid exchange (RX) delivery system.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Procedure SuccessTime frame: Periprocedural

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Cirugía Cardiovascular, Sanatorio Italiano

    Asunción, Paraguay

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.